EQA Program
Our external quality assessment (EQA) program is aimed at medical laboratories and point-of-care testing sites. The program includes more than 250 clinically relevant external quality assessment schemes and it is compliant with ISO 15189 standard requirements.
Changes in the 2025 program
New schemes and products
- 5850 Brucella antibodies
- 5241 Bordetella pertussis/parapertussis, nucleic acid detection
- 5687 HBsAg and HCVAb POCT
- 5251 Interferon Gamma Release Assay (IGRA) for Mycobacterium tuberculosis - whole blood sample
- 5686 Norovirus, antigen detection
- 2755 Holotranscobalamin (HoloTC) and Methylmalonic Acid
Planned pilot schemes
Pilot schemes are EQA schemes under our product development.
All changes are listed in the Product Catalogue on page 5.
Subscription for 2025 will open on 2 September 2024
Please subscribe to the 2025 EQA programs before the end of November 2024 to ensure your participation in all needed EQA rounds. You can renew your subscription by contacting our local partner in your country. Direct customers can renew their subscriptions on LabScala starting on 2 September 2024. If you need more information, please contact our customer service: info@aurevia.com.
Sales and Customer Service
Juha Wahlstedt
Jukka Korhonen
Minna Kankainen
Explore our services
EQA Product Catalogue
Our external quality assessment service program includes more than 250 quality assessment schemes, covering all specialities of laboratory medicine. Furthermore, the program includes an extensive selection of services designed for medical laboratories and point-of-care testing sites.
Integrated EQA Service
New EQA Schemes
Digital External Quality Assessment Programs
Our digital EQA product line provides an advanced approach to external quality assessment. Digital EQA programs or virtual EQA programs use digital images, videos, virtual microscopy technology, and questionnaires as EQA samples.